Showing results (131-140 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|February 6, 2010
Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s)David B Clifford, Scott Evans, Yijun Yang, et al.
HIV Clinical Trials|February 6, 2010
Monotherapy with Lopinavir/Ritonavir as maintenance after HIV-1 viral suppression: results of a 96-week randomized, controlled, open-label, pilot trial (KalMo study)Estevão P Nunes, Marilia Santini de Oliveira, Monica Merçon, et al.
HIV Clinical Trials|November 13, 2009
Causes and consequences of incomplete HIV RNA suppression in clinical trialsAnton Pozniak, Ravindra K Gupta, Deenan Pillay, et al.
HIV Clinical Trials|December 8, 2009
Comparison of nucleoside reverse transcriptase inhibitor use as part of first-line therapy in a Serbian and a UK HIV clinicG J Dragovic, C J Smith, D J Jevtovic, et al.
HIV Clinical Trials|March 10, 2017
Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trialMarkella V Zanni, Kathleen Fitch, Corinne Rivard, et al.
HIV Clinical Trials|July 28, 2009
Steady-state amprenavir, tenofovir, and emtricitabine pharmacokinetics before and after reducing ritonavir boosting of a fosamprenavir/tenofovir/emtricitabine regimen from 200 mg to 100 mg once daily (TELEX II)David A Parks, H Clay Jennings, Christopher Taylor, et al.
HIV Clinical Trials|October 25, 2007
Stavudine but not didanosine as part of HAART contributes to peripheral lipoatrophy: a substudy from the Antiretroviral Regimen Evaluation Study (ARES)Selwyn H Lowe, Elly A M Hassink, Berthe L F van Eck-Smit, et al.
HIV Clinical Trials|August 14, 2003
Combined analysis of two-year follow-up from two open-label randomized trials comparing efficacy of three nucleoside reverse transcriptase inhibitor backbones for previously untreated HIV-1 infection: OzCombo 1 and 2J Amin, A Moore, A Carr, et al.
HIV Clinical Trials|December 4, 2010
The effects of exercise training on metabolic and morphological outcomes for people living with HIV: a systematic review of randomised controlled trialsS Fillipas, C L Cherry, F Cicuttini, et al.
HIV Clinical Trials|December 4, 2010
Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138)Thomas Boulet, Juliette Pavie, Isabelle Charreau, et al.
Pageof 68